George Painter
Overview
Explore the profile of George Painter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bihorel S, Cao Y, Chawla A, Birger R, Maas B, Gao W, et al.
CPT Pharmacometrics Syst Pharmacol
. 2023 Oct;
12(12):1859-1871.
PMID: 37798914
Effective antiviral treatments for coronavirus disease 2019 (COVID-19) are needed to reduce the morbidity and mortality associated with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection, particularly in patients with risk...
2.
Holman W, Holman W, McIntosh S, Painter W, Painter G, Bush J, et al.
Trials
. 2021 Aug;
22(1):561.
PMID: 34425873
A recently published article described the safety, tolerability, and pharmacokinetic profile of molnupiravir (Painter et al. 2021), a novel antiviral agent with potent activity against severe acute respiratory syndrome coronavirus...
3.
Troth S, Butterton J, DeAnda C, Escobar P, Grobler J, Hazuda D, et al.
J Infect Dis
. 2021 Jul;
224(8):1442-1443.
PMID: 34251432
No abstract available.
4.
Hall M, Anderson J, Anderson A, Baker D, Bradner J, Brimacombe K, et al.
J Infect Dis
. 2021 Jun;
224(Supplement_1):S1-S21.
PMID: 34111271
The NIH Virtual SARS-CoV-2 Antiviral Summit, held on 6 November 2020, was organized to provide an overview on the status and challenges in developing antiviral therapeutics for coronavirus disease 2019...
5.
Wahl A, Gralinski L, Johnson C, Yao W, Kovarova M, Dinnon 3rd K, et al.
Nature
. 2021 Feb;
591(7850):451-457.
PMID: 33561864
All coronaviruses known to have recently emerged as human pathogens probably originated in bats. Here we use a single experimental platform based on immunodeficient mice implanted with human lung tissue...
6.
Sheahan T, Sims A, Zhou S, Graham R, Pruijssers A, Agostini M, et al.
Sci Transl Med
. 2020 Apr;
12(541).
PMID: 32253226
Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of COVID-19. Here, we show that the ribonucleoside...
7.
Liotta D, Painter G
ACS Med Chem Lett
. 2018 May;
9(5):403-407.
PMID: 29795749
Although there are hundreds of academic drug discovery centers open around the world, there are comparatively few academic drug development centers that contain the key core competencies needed to progress...
8.
9.
Parker S, Crump R, Foster S, Hartzler H, Hembrador E, Lanier E, et al.
Antiviral Res
. 2014 Aug;
111:42-52.
PMID: 25128688
Natural orthopoxvirus outbreaks such as vaccinia, cowpox, cattlepox and buffalopox continue to cause morbidity in the human population. Monkeypox virus remains a significant agent of morbidity and mortality in Africa....
10.